Citation: Rb. Weiss et al., HEMOLYTIC-ANEMIA AFTER FLUDARABINE THERAPY FOR CHRONIC LYMPHOCYTIC-LEUKEMIA, Journal of clinical oncology, 16(5), 1998, pp. 1885-1889
Citation: S. Loeb et al., EFFECT OF POROUS SUPPORT FABRIC ON OSMOSIS THROUGH A LOEB-SOURIRAJAN TYPE ASYMMETRIC MEMBRANE, Journal of membrane science, 129(2), 1997, pp. 243-249
Citation: Jc. Byrd et al., FATAL RECURRENCE OF AUTOIMMUNE HEMOLYTIC-ANEMIA FOLLOWING PENTOSTATINTHERAPY IN A PATIENT WITH A HISTORY OF FLUDARABINE-ASSOCIATED HEMOLYTIC-ANEMIA, Annals of oncology, 6(3), 1995, pp. 300-301
Authors:
BOROWITZ DS
GRAND RJ
DURIE PR
BEKER LT
DODGE JA
FINK RJ
FITZSIMMONS SC
FREIMAN J
KALNINS D
KIMURA R
KIRSCHNER B
LLOYDSTILL JD
LOWENFELS A
MAGUINESS K
ROBERTS IM
SCHWARZENBERG SJ
SMYTH RL
STEVENS JC
STONE RT
THOMPSON B
VANVELZEN D
WEST K
ZERIN JM
Citation: Ds. Borowitz et al., USE OF PANCREATIC-ENZYME SUPPLEMENTS FOR PATIENTS WITH CYSTIC-FIBROSIS IN THE CONTEXT OF FIBROSING COLONOPATHY, The Journal of pediatrics, 127(5), 1995, pp. 681-684
Citation: Ga. Burkhart et J. Freiman, THE RISK OF LIFE-THREATENING CARDIOVASCULAR EVENTS WITH TERFENADINE, The American journal of cardiology, 75(2), 1995, pp. 213-214